Related Experiment Video
Updated: May 6, 2026

04:41
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
7.9K
Differential microRNA expression profiles in peripheral arterial disease.
Philip W Stather1, Nicolas Sylvius, John B Wild
1Department of Cardiovascular Sciences and Department of Genetics and the NIHR Leicester Cardiovascular Biomedical Research Unit, University of Leicester, Leicester, United Kingdom.
Circulation. Cardiovascular Genetics
|October 17, 2013
Summary
A 12-microRNA (miRNA) signature in blood shows diagnostic potential for peripheral arterial disease (PAD). This discovery offers insights into PAD
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Peripheral arterial disease (PAD) is a significant vascular condition linked to atherosclerosis.
- Despite advancements, PAD remains a major cause of mortality and morbidity.
- MicroRNAs (miRNAs) are key gene regulators involved in various biological processes.
Purpose of the Study:
- To identify a miRNA-based signature for diagnosing PAD.
- To explore the role of miRNAs in the molecular mechanisms of PAD.
- To investigate potential therapeutic targets for PAD.
Main Methods:
- Whole-miRNA transcriptome profiling of peripheral blood samples.
- Validation of a 12-miRNA signature in independent patient cohorts.
- Receiver operating characteristic (ROC) curve analysis for diagnostic value assessment.
- Pathway enrichment analysis and candidate gene expression quantification.
Main Results:
- A specific 12-miRNA signature (let 7e, miR-15b, -16, -20b, -25, -26b, -27b, -28-5p, -126, -195, -335, -363) was identified and validated.
- The identified miRNAs demonstrated significant diagnostic value for PAD.
- Pathway analysis revealed links to vascular disorders, with inverse correlations between miRNA and candidate gene expression.
Conclusions:
- miRNAs hold promise as diagnostic biomarkers for PAD.
- The study provides insights into the molecular pathogenesis of PAD.
- These findings may pave the way for novel therapeutic strategies targeting miRNAs.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
773
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Peripheral Artery Disease I: Introduction
663
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663

